Cytogen Financials
| 217330 Stock | KRW 7,140 20.00 0.28% |
Cytogen |
Understanding current and past Cytogen Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Cytogen's financial statements are interrelated, with each one affecting the others. For example, an increase in Cytogen's assets may result in an increase in income on the income statement.
Please note, the presentation of Cytogen's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Cytogen's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Cytogen's management manipulating its earnings.
Cytogen Stock Summary
Cytogen competes with Koryo Credit, Daishin Information, SCI Information, Daou Data, and Sungchang Autotech. Cytogen, Inc., a biotechnology company, develops and sells CTC enrichment and downstream systems to treat cancer in South Korea. Cytogen, Inc. was founded in 2010 and is headquartered in Seoul, South Korea. Cytogen is traded on Korean Securities Dealers Automated Quotations in South Korea.| Instrument | Korea Stock View All |
| Exchange | KOSDAQ |
| ISIN | KR7217330000 |
| Business Address | SK V1 GL |
| Sector | Healthcare |
| Industry | Biotechnology & Medical Research |
| Benchmark | Dow Jones Industrial |
| Website | www.cytogenlab.com |
| Phone | 82 2 6925 1070 |
| Currency | KRW - South Korean Won |
You should never invest in Cytogen without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Cytogen Stock, because this is throwing your money away. Analyzing the key information contained in Cytogen's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Cytogen Key Financial Ratios
Cytogen's financial ratios allow both analysts and investors to convert raw data from Cytogen's financial statements into concise, actionable information that can be used to evaluate the performance of Cytogen over time and compare it to other companies across industries.| Return On Equity | -96.72 | |||
| Return On Asset | -0.18 | |||
| Beta | 1.16 | |||
| Z Score | 2.4 |
Cytogen Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Cytogen's current stock value. Our valuation model uses many indicators to compare Cytogen value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cytogen competition to find correlations between indicators driving Cytogen's intrinsic value. More Info.Cytogen is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Cytogen by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Cytogen's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Cytogen Systematic Risk
Cytogen's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Cytogen volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Cytogen correlated with the market. If Beta is less than 0 Cytogen generally moves in the opposite direction as compared to the market. If Cytogen Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Cytogen is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Cytogen is generally in the same direction as the market. If Beta > 1 Cytogen moves generally in the same direction as, but more than the movement of the benchmark.
Cytogen November 29, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Cytogen help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Cytogen. We use our internally-developed statistical techniques to arrive at the intrinsic value of Cytogen based on widely used predictive technical indicators. In general, we focus on analyzing Cytogen Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Cytogen's daily price indicators and compare them against related drivers.
| Information Ratio | (0.06) | |||
| Maximum Drawdown | 16.92 | |||
| Value At Risk | (4.64) | |||
| Potential Upside | 5.61 |
Complementary Tools for Cytogen Stock analysis
When running Cytogen's price analysis, check to measure Cytogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cytogen is operating at the current time. Most of Cytogen's value examination focuses on studying past and present price action to predict the probability of Cytogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cytogen's price. Additionally, you may evaluate how the addition of Cytogen to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |